Trial
NCT03663166
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
Thoracic Radiotherapy
Why stopped
Increased SAE occurrence per PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-15